Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 3/2008

01.12.2008 | Original Article

Comparison of Two School-Based Smoking Prevention Programs among South African High School Students: Results of a Randomized Trial

verfasst von: Ken Resnicow, Ph.D., Sasiragha Priscilla Reddy, Ph.D., Shamagonam James, Ph.D., Riyadh Gabebodeen Omardien, Nilen Sunder Kambaran, Heinrich George Langner, Roger D. Vaughan, Ph.D., Donna Cross, Ed.D., Greg Hamilton, Ph.D., Tracy Nichols, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Smoking rates are projected to increase substantially in developing countries such as South Africa.

Purpose

The aim of this study was to test the efficacy of two contrasting approaches to school-based smoking prevention in South African youth compared to the standard health education program. One experimental program was based on a skills training/peer resistance model and the other on a harm minimization model.

Method

Thirty-six public schools from two South African provinces, KwaZulu-Natal and the Western Cape, were stratified by socioeconomic status and randomized to one of three groups. Group 1 (comparison) schools (n = 12) received usual tobacco use education. Group 2 schools (n = 12) received a harm minimization curriculum in grades 8 and 9. Group 3 schools (n = 12) received a life skills training curriculum in grades 8 and 9. The primary outcome was past month use of cigarettes based on a self-reported questionnaire.

Result

Five thousand two hundred sixty-six students completed the baseline survey. Of these, 4,684 (89%) completed at least one follow-up assessment. The net change in 30-day smoking from baseline to 2-year follow-up in the control group was 6% compared to 3% in both harm minimization (HM) and life skills training (LST) schools. These differences were not statistically significant. Intervention response was significantly moderated by both gender and race. The HM intervention was more effective for males, whereas the life skills intervention was more effective for females. For black African students, the strongest effect was evident for the HM intervention, whereas the strongest intervention effect for “colored” students was evident for the LST group.

Conclusion

The two experimental curricula both produced similar overall reductions in smoking prevalence that were not significantly different from each other or the control group. However, the impact differed by gender and race, suggesting a need to tailor tobacco and drug use prevention programs. More intensive intervention, in the classroom and beyond, may be needed to further impact smoking behavior.
Fußnoten
1
^ = Design Effect is 1 + ρ (m − 1) where m = average number of subjects per school and ρ is the computed intracluster correlation coefficient.
 
Literatur
1.
Centers for Disease Control and P. Cigarette use among high school students—United States, 1991–2005. MMWR–Morb Mort Wkly Rep. 2006; 55: 724–726.
2.
White V, Hill D, Siahpush M, Bobevski I. How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001. Tob Control. 2003; 12(Suppl 2): ii67–ii74.PubMed
3.
Hill D, White V, Effendi Y. Changes in the use of tobacco among Australian secondary students: Results of the 1999 prevalence study and comparisons with earlier years. Aust N Z J Public Health. 2002; 26: 156–163.PubMedCrossRef
4.
Health Canada. Youth smoking in Canada. CTUMS (Canadian Tobacco Use Monitoring Survey), February–December 2000. 2004.
5.
World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: WHO; 2002.
6.
Lando HA, Borrelli B, Klein LC, et al. The landscape in global tobacco control research: A guide to gaining a foothold. Am J Public Health. 2005; 95: 939–945.PubMedCrossRef
7.
Warren CW, Riley L, Asma S, et al. Tobacco use by youth: A surveillance report from the Global Youth Tobacco Survey project. Bull WHO. 2000; 78: 868–876.PubMed
8.
Swart D, Reddy P, Ruiter RA, de Vries H. Cigarette use among male and female grade 8–10 students of different ethnicity in South African schools. Tob Control. 2003; 12: E1.PubMedCrossRef
9.
Reddy P, Resnicow K, Omardien R, Kambaran N. Prevalence and correlates of substance use among high school students in South Africa and the United States. Am J Public Health. 2007; 97: 1859–1864.PubMedCrossRef
10.
Centers for Disease Control and Prevention. Guidelines for school health programs to prevent tobacco use and addiction. J Sch Health. 1994; 64: 353–360.
11.
Glynn TJ. School based smoking prevention trials at the U.S. National Cancer Institute: Results and recommendations. Tobacco and Health 1990 The Global War. Perth, WA; 1990.
12.
Glynn TJ, Anderson DM, Schwarz L. Tobacco-use reduction among high-risk youth: Recommendations of a National Cancer Institute expert advisory panel. Prev Med. 1991; 20: 279–291.PubMedCrossRef
13.
U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2000.
14.
de Vries H, Candel M, Engels R, Mercken L. Challenges to the peer influence paradigm: Results for 12–13 year olds from six European countries from the European Smoking Prevention Framework Approach study. Tob Control. 2006; 15: 83–89.PubMedCrossRef
15.
Steptoe A, Wardle J, Cui W, et al. An international comparison of tobacco smoking, beliefs and risk awareness in university students from 23 countries. Addiction. 2002; 97: 1561–1571.PubMedCrossRef
16.
Sly DF, Heald GR, Ray S. The Florida “truth” anti-tobacco media evaluation: Design, first year results, and implications for planning future state media evaluations. Tob Control. 2001; 10: 9–15.PubMedCrossRef
17.
Farrelly MC, Davis KC, Haviland ML, Messeri P, Healton CG. Evidence of a dose–response relationship between “truth” antismoking ads and youth smoking prevalence. Am J Public Health. 2005; 95: 425.PubMedCrossRef
18.
Botvin G, Eng A. The efficacy of a multicomponent approach to the prevention of cigarette smoking. Prev Med. 1982; 11: 199–211.PubMedCrossRef
19.
Botvin G, Baker E, Renick N, Filazzola A, Botvin E. A cognitive–behavioral approach to substance abuse prevention. Addict Behav. 1984; 9: 137–147.PubMedCrossRef
20.
Botvin G, Dusenbury L, Baker E, James-Ortiz S, Kerner J. A skills training approach to smoking prevention among Hispanic youth. J Behav Med. 1989; 12: 279–295.PubMedCrossRef
21.
Botvin GJ, Baker E, Dunsenbury L, Tortu S, Botvin E. Preventing adolescent drug abuse through a multimodal congintive–behavioral approach: Results of a three year study. J Consult Clin Psychol. 1990; 58: 437–446.PubMedCrossRef
22.
Botvin G, Baker E, Dusenbury L, Botvin E, Diaz T. Long-term follow-up results of a randomized drug use prevention trial in a white middle-class population. JAMA. 1995; 273: 1106–1112.PubMedCrossRef
23.
Botvin G, Epstein J, Schinke S, Diaz T. Predictors of cigarette smoking among inner-city minority youth. J Dev Behav Pediatr. 1994; 15: 67–73.PubMedCrossRef
24.
Botvin G, Dusenbury L. Smoking prevention among urban minority youth: Assessing effects on outcome and mediating variables. Health Psychol. 1992; 11: 290–299.PubMedCrossRef
25.
Botvin GJ, Schinke SP, Epstein JA, Diaz T, Botvin EM. Effectiveness of culturally focused and generic skills training approaches to alcohol and drug abuse prevention among minority adolescents: Two-year follow-up results. Psychol Addict Behav. 1995; 9: 183–194.CrossRef
26.
Botvin GJ, Schinke SP, Epstein JA, Diaz T. Effectiveness of culturally focused and generic skills training approaches to alcohol and drug abuse prevention among minority youths. Psychol Addict Behav. 1994; 8: 116–127.CrossRef
27.
Botvin GJ, Griffin KW, Diaz T, Miller N, Ifill-Williams M. Smoking initiation and escalation in early adolescent girls: One-year follow-up of a school-based prevention intervention for minority youth. J Am Med Women’s Assoc. 1999; 54: 139–143. 152.
28.
Botvin GJ, Griffin KW, Diaz T, et al. Preventing illicit drug use in adolescents: Long-term follow-up data from a randomized control trial of a school population. Addict Behav. 2000; 25: 769–774.PubMedCrossRef
29.
Botvin GJ. Preventing drug abuse in schools: Social and competence enhancement approaches targeting individual-level etiologic factors. Addict Behav. 2000; 25: 887–897.PubMedCrossRef
30.
Resnicow K, Botvin G. On the effects of school health education programs: Why do they decay? Prev Med. 1993; 22: 484–490.PubMedCrossRef
31.
Wiehe SE, Garrison MM, Christakis DA, Ebel BE, Rivara FP. A systematic review of school-based smoking prevention trials with long-term follow-up. J Adolesc Health. 2005; 36: 162–169.PubMedCrossRef
32.
Skara S, Sussman S. A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations. Prev Med. 2003; 37: 451–474.PubMedCrossRef
33.
Spoth R, Randalla G, Trudeaua L, Shina C, Redmond C. Substance use outcomes 51/2 years past baseline for partnership-based, family-school preventive interventions. Drug Alcohol Depend. 2008; 96: 57–68.PubMedCrossRef
34.
Flay B. The Long-term promise of effective school-based smoking prevention programs: Appendix D. In: Bonnie R, Stratton K, Wallace R, eds. Ending the Tobacco Problem: A Blueprint for the Nation. Washington, DC: Institute of Medicine; 2007: 449–477.
35.
Seal N. Preventing tobacco and drug use among Thai high school students through life skills training. Nursing and Health Sciences. 2006; 8: 164–168.PubMedCrossRef
36.
Peterson AV Jr., Kealey KA, Mann SL, Marek PM, Sarason IG. Hutchinson smoking prevention project: Long-term randomized trial in school-based tobacco use prevention—results on smoking. J Natl Cancer Inst. 2000; 92: 1979–1991.PubMedCrossRef
37.
Thomas R. School-based programmes for preventing smoking [update in Cochrane Database Syst Rev.;3:CD001293; PMID: 16855966]. 2006:CD001293, 002002.
38.
Bell R, Ellickson P, Harrison E. Do drug prevention effects persist into high school? How project alert did with ninth graders. Prev Med. 1993; 22: 463–483.PubMedCrossRef
39.
Perry C, Kelder S, Murray D, Klepp K. Communitywide smoking prevention: Long-term outcomes of the Minnesota Heart Health Program of the Class of 1989 study. Am J Public Health. 1992; 82: 1210–1216.PubMedCrossRef
40.
Elder J, Wildey M, de Moor C, et al. The long-term prevention of tobacco use among junior high school students: Classroom and telephone interventions. Am J Public Health. 1993; 83: 1239–1244.PubMedCrossRef
41.
Wiehe SE, Garrison MM, Christakis DA, Ebel BE, Rivara FP. A systematic review of school-based smoking prevention trials with long-term follow-up. J Adolesc Health. 2005; 36(3): 162–169.PubMedCrossRef
42.
Hansen W, Graham J. Preventing alcohol, marijuana, and cigarette use among adolescents: Peer pressure resistance training versus establishing conservative norms. Prev Med. 1991; 20: 414–430.PubMedCrossRef
43.
Donaldson S, Graham J, Piccinin A, Hansen W. Resistance-skills training and onset of alcohol use: Evidence for beneficial and potentially harmful effects in public schools and in private Catholic schools. Health Psychol. 1995; 14: 291–300.PubMedCrossRef
44.
Sussman S, Dent C, Stacy A, et al. Project towards no tobacco use, 1-year behavior outcomes. Am J Public Health. 1993; 83: 1245–1250.PubMedCrossRef
45.
Donaldson SI, Graham JW, Hansen WB. Testing the generalizability of intervening mechanism theories: Understanding the effects of adolescent drug use prevention interventions. J Behav Med. 1994; 17: 195–216.PubMedCrossRef
46.
Donaldson SI, Sussman S, MacKinnon DP, et al. Drug abuse prevention programming: Do we know what content works? Am Behav Sci. 1996; 39: 868–883.CrossRef
47.
Palinkas LA, Atkins CJ, Miller C, Ferreira D. Social skills training for drug prevention in high-risk female adolescents. Prev Med. 1996; 25: 692–701.PubMedCrossRef
48.
Elder J, Sallis J, Woodruff S, Wildey M. Tobacco-refusal skills and tobacco use among high risk adolescents. J Behav Med. 1993; 16: 629–642.PubMedCrossRef
49.
Resnicow K, Smith M, Harrison L, Drucker E. Correlates of occasional tobacco and marijuana use: Are teens harm reducing? Addict Behav. 1999; 24: 251–266.PubMedCrossRef
50.
Hamilton G, Cross D, Resnicow K. Occasional cigarette smokers: Cue for harm reduction smoking education. Addict Res. 2000; 8: 419–437.CrossRef
51.
Des Jarlais D, Friedman S, Ward T. Harm reduction: A public health response to the AIDS epidemic among injecting drug users. Annu Rev Public Health. 1993; 14: 413–450.PubMedCrossRef
52.
Drucker E. Harm reduction: A public health strategy. Curr Issues Public Health. 1995; 1: 64–70.
53.
Duncan DF, Nicholson T, Clifford P, Hawkins W, Petosa R. Harm reduction: An emerging new paradigm for drug education. J Drug Educ. 1994; 24: 281–290.PubMed
54.
Resnicow K, Drucker E. Reducing the harm of a failed drug control policy. Am Psychol. 1999; 54: 842–843.PubMedCrossRef
55.
Borland R, Scollo M. Opportunities for harm minimisation in tobacco control. Drug Alochol Rev. 1999; 18: 345–353.CrossRef
56.
West R. Smoking: Its influence on survival and cause of death. Journal of Royal College of Physicians of London. 1992; 26: 357–36654.
57.
Zang E, Wynder E. Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. Cancer. 1992; 70: 69–76.PubMedCrossRef
58.
Kondo K, Tsuzuki H, Sasa M, et al. A dose -response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. J Surg Oncol. 1996; 61: 20–26.PubMedCrossRef
59.
Menhiratta S, Wig N, Verma S. Some psychological correlates of long-term heavy cannabis users. Br J Psychiatry. 1978; 132: 482–486.PubMedCrossRef
60.
Torabi M, Bailey W, Majd-Jabbari M. Cigarette smoking as a predictor of alcohol and other drug use by children and adolescents: Evidence of the “gateway drug effect”. J Sch Health. 1993; 63: 302–306.PubMed
61.
Kandel D, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: Further evidence for the gateway theory. J Stud Alcohol. 1992; 53: 447–457.PubMed
62.
Kouri E, Pope HG Jr., Yurgelun-Todd D, Gruber S. Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry. 1995; 38: 475–481.PubMedCrossRef
63.
Willard J, Schoenborn C. Relationship between cigarette smoking and other unhealthy behaviours among our nation’s youth: United States 1992 No. 264: National Center for Health Statistics, CDC; 1995.
64.
Klonoff H, Clark C. Drug patterns in the chronic marijuana user. Int J Addict. 1976; 11: 71–80.PubMed
65.
Kimlicka TM. A comparison of chronic versus casual marijuana users on personal values and behavioral orientations. Int J Addict. 1978; 13: 1145–1156.PubMed
66.
McWhorter WP, Boyd GM, Mattson ME. Predictors of quitting smoking: The NHANES I follow-up experience. J Clin Epidemiol. 1990; 43: 1399–1405.PubMedCrossRef
67.
Shiffman S. Tobacco “chippers”—individual differences in tobacco dependence. Psychopharmacology. 1989; 97: 539–547.PubMedCrossRef
68.
69.
Wilson D, Wakefield M, Owen N, Roberts L. Characteristics of heavy smokers. Prev Med. 1992; 21: 311–319.PubMedCrossRef
70.
Shedler J, Block J. Adolescent drug use and psychological health. A longitudinal inquiry. Am Psychol. 1990; 45: 612–630.PubMedCrossRef
71.
Hamilton G, Cross D, Resnicow K, Hall M. A school-based harm minimization smoking intervention trial: Outcome results. Addiction. 2005; 100: 689–700.PubMedCrossRef
72.
Hamilton G, Cross D, Resnicow K, Shaw T. Does harm minimisation lead to greater experimentation? Results from a school smoking intervention trial. Drug Alcohol Rev. 2007; 26: 605–613.PubMedCrossRef
73.
Reddy S, Panday S, Swart D, et al. Umthenthe Uhlaba Usamila—The South African Youth Risk Behaviour Survey 2002. Capetown, South Africa: South African Medical Research Council; 2003.
74.
Killip S, Mahfoud Z, Pearce K. What is an intracluster correlation coefficient? Crucial concepts for primary care researchers. Annals of Family Medicine. 2004; 2: 204–208.PubMedCrossRef
75.
Crossett LS, Everett SA, Brener ND, Fishman JA, Pechacek TF. Adherence to the CDC guidelines for school health programs to prevent tobacco use and addiction. J Health Educ. 1999; 30: S4–S11.
76.
Dijkstra M, Mesters I, De Vries H, van Breukelen G, Parcel G. Effectiveness of a social influence approach and boosters to smoking prevention. Health Educ Res. 1999; 14: 791–802.PubMedCrossRef
77.
Flay BR. Approaches to substance use prevention utilising school curriculum plus social environment change. Addict Behav. 2000; 25: 861–885.PubMedCrossRef
78.
Lantz PM, Jacobson PD, Warner KE, et al. Investing in youth tobacco control: A review of smoking prevention and control strategies. Tob Control. 2000; 9: 47–63.PubMedCrossRef
79.
Pentz M, Dwyer J, MacKinnon D, et al. A multicommunity trial for primary prevention of adolescent drug abuse. Effects on drug use prevalence. JAMA. 1989; 261: 3259–3266.PubMedCrossRef
80.
Pentz MA, MacKinnon DP, Dwyer JH, et al. Longitudinal effects of the Midwestern Prevention Project on regular and experimental smoking in adolescents. Prev Med. 1989; 18: 304–321.PubMedCrossRef
81.
Wakefield M, Flay B, Nichter M, Giovino G. Role of the media in influencing trajectories of youth smoking. Addiction. 2003; 98(Suppl 1): 79–103.PubMedCrossRef
82.
Skara S, Sussman S. A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations. Prev Med. 2003; 37: 451–474.PubMedCrossRef
83.
Waldron I, Lye D, Brandon A. Gender differences in teenage smoking. Women Health. 1991; 17: 65–90.PubMedCrossRef
84.
Fergusson DM, Horwood LJ, Lynskey MT. The comorbidities of adolescent problem behaviors: A latent class model. J Abnorm Child Psychol. 1994; 22: 339–354.PubMedCrossRef
85.
Fernander AF, Flisher AJ, King G, et al. Gender differences in depression and smoking among youth in Cape Town, South Africa. Ethn Dis. 2006; 16: 41–50.PubMed
86.
Blitstein JL, Robinson LA, Murray DM, Klesges RC, Zbikowski SM. Rapid progression to regular cigarette smoking among nonsmoking adolescents: Interactions with gender and ethnicity. Prev Med. 2003; 36: 455–463.PubMedCrossRef
87.
Guthrie BJ, Young AM, Boyd CJ, Kintner EK. Dealing with daily hassles: Smoking and African-American adolescent girls. J Adolesc Health. 2001; 29: 109–115.PubMedCrossRef
88.
van Roosmalen EH, McDaniel SA. Adolescent smoking intentions: Gender differences in peer context. Adolescence. 1992; 27: 87–105.PubMed
89.
90.
Luke D, Allen P, Arian G, et al. Teens’ images of smoking and smokers. Public Health Rep. 2001; 116(Suppl 1): 194–202.PubMedCrossRef
91.
Clayton S. Gender differences in psychosocial determinants of adolescent smoking. J Sch Health. 1991; 61: 115–120.PubMedCrossRef
92.
Botvin G, Baker E, Filazzola A, Botvin E. A cognitive-behavioral approach to substance abuse prevention: One-year follow-up. Addict Behav. 1990; 15: 47–63.PubMedCrossRef
93.
Biko S. I Write What I Like. Johannesburg, South Africa: Heinemann; 1978.
94.
Ramose MB. The philosophy of ubuntu and ubuntu as a philosophy. In: Coetzee P, Roux A, eds. The African Philosophy Reader. New York: Routledge; 2003: 230–238.
Metadaten
Titel
Comparison of Two School-Based Smoking Prevention Programs among South African High School Students: Results of a Randomized Trial
verfasst von
Ken Resnicow, Ph.D.
Sasiragha Priscilla Reddy, Ph.D.
Shamagonam James, Ph.D.
Riyadh Gabebodeen Omardien
Nilen Sunder Kambaran
Heinrich George Langner
Roger D. Vaughan, Ph.D.
Donna Cross, Ed.D.
Greg Hamilton, Ph.D.
Tracy Nichols, Ph.D.
Publikationsdatum
01.12.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 3/2008
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-008-9072-5

Weitere Artikel der Ausgabe 3/2008

Annals of Behavioral Medicine 3/2008 Zur Ausgabe

Original Article

Predicting the Physical Activity Intention–Behavior Profiles of Adopters and Maintainers Using Three Social Cognition Models

Original Article

Psychological Factors Influencing Self-Assessments of Health: Toward an Understanding of the Mechanisms Underlying How People Rate Their Own Health

Original Article

Dispositional Optimism and Thoughts of Well-Being Determine Sensitivity to an Experimental Pain Task

Original Article

Emergency Department Initiated Treatments for Tobacco (EDITT): A Pilot Study

Original Article

Exercise, Fitness, and Neurocognitive Function in Older Adults: The “Selective Improvement” and “Cardiovascular Fitness” Hypotheses

Original Article

What is Needed to Reverse the Trends in Childhood Obesity? A Call to Action

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Bildnachweise